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ABSTRACT 
International Journal of Exercise Science V(i): X-Y, YEAR. Significant positive 
correlations are often observed between vitamin D concentrations and physical activity levels. 
Whilst this may be due to individuals who are physically active spending time outdoors (i.e. 
increased opportunity for vitamin D synthesis), there is growing evidence to suggest a more 
complex relationship between vitamin D status, physical fitness and health outcomes.  To explore 
this further thirty-nine healthy adults were randomly allocated to 15 weeks of exercise training 
(Ex), no training (NoEx), 2000 IU/day vitamin D (VitD) and/or placebo (Pla) supplementation 
(giving four possible allocations: NoEx+VitD; NoEx+Pla; Ex+VitD; Ex+Pla). Vitamin D status, 
glycaemic control and exercise responses were measured pre- and post-intervention. A series of 2 
x 2 ANOVAs failed to find any effect of supplementation or exercise on any of the measures except 
heart rate during low intensity exercise, and vitamin D status. Heart rate was significantly reduced 
(6%, p < 0.05) in the Ex+VitD group. Vitamin D status was significantly raised (28%, p < 0,05) in 
the supplementation groups (NoEx+VitD and Ex+VitD) at a time of year (August-November) 
when a seasonal decline was observed in the placebo groups (33%, p < 0.05). These findings 
indicate that vitamin D supplementation (2000 IU/day) may have an enhancing role alongside 
exercise in inducing cardiorespiratory adaptations to exercise training. Further investigations are 
required to confirm these findings and identify the mechanisms involved. 
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INTRODUCTION 
 
Once only recognised for its role in bone 
and mineral homeostasis, there is emerging 
evidence that vitamin D exerts a range of 
effects on many aspects of both human 
health (19) and physical performance (9). 
Positive correlations have frequently been 
observed between vitamin D status, 
physical activity and physical fitness (7). 
Whilst there is still much work to be done 
in this area it is becoming apparent that the 
higher levels vitamin D observed in those 
who are more physically active may not 
simply be due to increased sun exposure 
alone.  
Whether orally ingested or obtained via 
sunlight, vitamin D is biologically inert and 
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requires two consecutive hydroxylations to form 
it’s biologically active form; 1,25 
dihydroxyvitamin D3. The first part of this 
process occurs in the liver which produces 25 
hydroxyvitamin D (25(OH)D), a pre-hormone 
which is used worldwide as a measure of 
vitamin D status (19).  
Exercise training results in increased 
muscle mass and induces increases in 
mitochondrial mass, volume, and 
mitochondrial enzymes (2). The 
mitochondria are essential sites for the 
biosynthesis of steroid hormones with the 
mitochondrial P450 enzymes being crucial 
for the activation and degradation of 
vitamin D (12), consequently any 
alterations in mitochondrial volume and 
enzymatic actions could affect vitamin D 
metabolism and status. Exercise training 
also results in a reduction in fat mass (6), 
and inverse associations have been 
observed between adiposity and 25(OH)D 
concentrations (5). When vitamin D is 
sequestered in the adipose tissue it is 
unavailable for biological processes within 
the body (17; 4), therefore any reductions in 
adipose tissue could result in an increase in 
circulating 25(OH)D. 
Several plausible mechanisms have been 
suggested (12; 19) by which increasing 
physical activity and increasing 25(OH)D 
status could have additive effects working 
together to increase cardiorespiratory 
fitness. A reduction in both resting and 
exercising HRs are frequently observed 
when individuals engage in a regular 
physical activity program of an adequate 
volume (1). There is some evidence that 
increasing vitamin D status may also result 
in a reduction in heart rate (13), potentially 
mediated via a vascular smooth muscle 
mechanism as this is a target organ for 
vitamin D action (13).  
It is well recognised that physical activity 
can reduce insulin resistance in skeletal 
muscle (8). It has also been suggested that 
via its effects on muscle metabolism 
vitamin D has an effect on insulin 
sensitivity (10). Vitamin D receptors and 
the enzymes required for its actions have 
been identified in numerous tissues 
including skeletal muscle where 
approximately 85% of insulin and calcium 
mediated glucose uptake takes place. 
Vitamin D regulates calcium homeostasis, 
and calcium plays a vital role in exercise 
induced glucose uptake (10). Therefore it is 
plausible that vitamin D may affect glucose 
uptake in skeletal muscle (15), 
independently and/or in combination with 
exercise.  
It is hypothesised that vitamin D 
supplementation and physical activity will 
exert both an independent and interactive 
effect on body composition, glycaemic 
control, and exercise response in healthy 
adults. 
 
METHODS 
 
Participants 
The experimental protocol was approved by 
Aberystwyth University Ethics Committee 
and was performed during 2012 (August – 
November) in accordance with the 
Declaration of Helsinki (2008). 
Participants were recruited via posters 
displayed around the local area and study 
information was included in the weekly 
University email. Eligible participants were 
aged ≥ 18 years and did not meet any of the 
exclusion criteria: (1) diagnosis of diabetes, 
(2) current use of vitamin D supplements 
and (3) any contraindication for moderate 
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intensity exercise - as assessed by physical 
activity readiness questionnaire. Written 
informed consent was obtained from thirty-
nine individuals who were not taking part in 
any form of structured exercise training. 
 
Table 1. participant characteristics (mean ± SD). 
 Age 
(years) 
Height 
(cm) 
Weight 
(kg) 
Ex+VitD 44.8±11.4 166.8±10.7 71.7±16.5 
NoEx+Vit D 42.3±16.9 166.7±11.1 69.1±15.1 
Ex+Pla 44.6±11.5 169.8±8.3 63.0±24.3 
NoEx+Pla 35.7±15.2 169.6±9.1 72.3±32.7 
 
Protocol 
Experimental Groups 
Thirty nine participants were randomised 
(computer-generated random allocation 
sequence) to one of four groups: (1) vitamin 
D supplementation (NoEx+VitD, males = 2; 
females = 8), (2) placebo supplementation 
(NoEx+Pla, males = 2; females = 9) (3) 
exercise plus vitamin D supplementation 
(Ex+VitD, males = 2; females = 8) and (4) 
exercise plus placebo (Ex+Pla males = 2; 
females = 6).  
All participants were instructed to take one 
capsule (size 00; 100% HIDE gelatine 
derived from the bovine skin, Blackburn 
Distributions LTD, Lancashire, UK) twice a 
day. Vitamin D capsules contained 25 µg of 
vitamin D (1000 IU) (Healthspan, Gurnsey, 
UK) and microcrystalline cellulose powder, 
99.12% purity (Blackburn Distributions 
LTD, Lancashire, UK); the placebo contained 
only the microcrystalline cellulose. 
Participants were invited back to the 
laboratory every 35 days to return used 
capsule pots and collect a new supply, 
enabling adherence to the supplementation 
protocol to be monitored. 
Prior to commencing the exercise training 
program the exercise groups participants 
completed a sub-maximal exercise test (see 
“measures” below) used to establish heart 
rate (HR) response and determine program 
workloads. Participants were required to 
attend a minimum of two exercise sessions a 
week (on different days). All sessions 
consisted of a 10-minute warm up and a 5-
minute cool down which were performed at 
40-50% of the HR reserve. Exercise sessions 
were alternated between interval and 
continuous exercise. During week one the 
continuous sessions consisted of 10 minutes 
steady state cycling at 60-75% HR reserve, 
which increased by ten minutes in week 
two, and a further ten minutes in week three. 
Participants continued to cycle for 30 
minutes at 60-75% HR reserve in these 
sessions for the remainder of intervention 
period. The interval phase started at 10 
minutes in week one and increased by five 
minutes each week until 30 minutes was 
reached. The interval sessions began with a 
2-minute low intensity phase at 40-50% HR 
reserve alternated with two minutes of high 
intensity periods at 80-90% HR reserve. 
Once built up, each exercise session lasted 
approximately 45 minutes. 
Participants in the exercise groups 
completed an additional sub-maximal 
exercise test mid-way through the exercise 
program for recalculation of exercise 
workloads. 
Measures 
All measures were completed at baseline 
and at 15 weeks (2-3 days post intervention). 
Participants attended the laboratory at each 
time point, one visit included venous blood 
sampling and an oral glucose tolerance test, 
and the second visit, completion of the 
International Physical Activity 
Questionnaire (www.ipaq.ki.se.) and a 
submaximal exercise test.  
Blood sampling and analyses: Following an 
overnight fast participants attended the 
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laboratory where they remained seated for 
10 minutes prior to blood being drawn from 
an antecubital vein (BD Vacutainer Precision 
Glide Multi Sample Needle, Plymouth, UK) 
and collected in to one 6 ml BD 367873 
plastic serum tube (red top) and one 6 ml 
K2EDTA plasma tube (lavender top). 
The 6 ml BD serum tube was kept at room 
temperature for 1.5 hours prior to being 
centrifuged at 4°C for 10 minutes at 1300 g to 
separate serum which was stored at -80˚C. 
Samples were transported to Merthyr Tydfil 
biochemistry laboratories (United 
Kingdom) for analyses of 25(OH)D (Agilent 
6410 Series Triple Quadrupole LC-MS/MS). 
0.5 ml of whole blood was removed from the 
6 ml K2EDTA plasma tube and refrigerated 
in an Eppendorf tube prior to analyses for 
glycated haemoglobin concentrations (D-10 
HbA1c analyser, Bio-Rad Laboratories Ltd). 
Remaining blood was centrifuged at 4°C for 
10 minutes at 1500 g to separate plasma, 0.5 
ml aliquots were stored at -80˚C. Following 
thawing at room temperature the frozen 0.5 
ml plasma samples were analysed for 
insulin concentrations using an Invitron 
Insulin Assay (IV2-001; Invitron Ltd, 
Monmouth, UK).  
International Physical Activity Questionnaire 
(IPAQ): The IPAQ short version captures 
both volume and number of physical 
activity sessions/days. Participants may 
then be categorised to one of three physical 
activity levels: (1) inactive (does not meet 
criteria for categories 2 or 3), (2) sufficiently 
active (3 or more days of vigorous activity of 
at least 20 minutes per day OR 5 or more 
days of moderate-intensity activity or 
walking of at least 30 minutes per day OR 5 
or more days of any combination of walking, 
moderate-intensity or vigorous intensity 
activities achieving a minimum of at least 
600 MET-min/week) or (3) active (vigorous-
intensity activity on at least 3 days achieving 
a minimum of at least 1500 MET-
minutes/week OR 7 or more days of any 
combination of walking, moderate-intensity 
or vigorous intensity activities achieving a 
minimum of at least 3000 MET-
minutes/week).  
Oral Glucose Tolerance Test: Following the 
venous blood sample participants ingested 
75 grams of glucose in 300 ml of water. 
Finger prick capillary blood samples were 
taken pre ingestion and 20, 40, 60, 80, 100, 
and 120 minutes post ingestion and 
analysed for glucose (2300 STAT PLUS, YSI, 
Yellow Springs, USA). Participants 
remained seated during this process. From 
the blood glucose values at each time point 
total area under the curve (AUC) was 
calculated. 
Sub-maximal exercise test (ACSM 2014): 
Participants were seated in the laboratory 
for 15 minutes to obtain resting HR. To 
establish each individual’s HR - work rate 
relationship participants performed a sub-
maximal exercise test on a cycle ergometer 
(Monark, 874E, Varberg, Sweden). The 
protocol consisted of four, four-minute work 
stages at 60, 90, 120 and 150 W. At the end of 
each stage HR was recorded and a linear 
regression equation was established 
between workload and HR. Individualised 
exercise workloads were then determined 
from the specific percentages of HR reserve 
(3).  
 
Statistical Analysis 
Statistical analyses were carried out using 
the Statistical Package for the Social Sciences 
(SPSS) (IBM SPSS Statistics for Windows, 
Version 21.0. Armonk, NY: IBM Corp). Data 
were checked for normal distribution using 
the Shapiro-Wilk test prior to statistical 
analysis. Statistical comparisons were made 
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using a 2-way mixed ANOVA. The four 
groups were the between subjects factor, and 
the time points the within subjects factor. 
Where appropriate, t-tests with Bonferroni 
corrections were conducted. 
 
RESULTS 
 
Two participants from the NoEx+VitD 
group and one from the NoEx+Pla group 
withdrew from the study; their data were 
removed from all analyses. All of the 
participants in the exercise groups 
completed the 15-week intervention 
program. Adherence to the two cycling 
sessions per week over 15 weeks was 92%. 
There were no significant differences in 
baseline characteristics between the four 
groups (Table 1). When recruited all 
participants verbally reported that they 
were inactive; however when they 
completed the IPAQ the results identified 
19% of participants as being inactive, 53% 
were sufficiently active  and 28% were 
categorised as being active.  
 
Vitamin D Status 
A two-way mixed ANOVA revealed a 
significant main effect of vitamin D 
supplementation on 25(OH)D 
concentrations in the vitamin D 
supplementation groups (F(1,30) = 36.276, 
MSe = 617.520, p < 0.001), however there was 
no main effect of exercise (F(1,30) = 0.228, p 
= 0.64) and no interaction of vitamin D and 
exercise (F(1,30) = 0.58, p = 0.81). Dependant 
t-tests identified significant differences 
(increase) in 25(OH)D concentration from 
pre to post intervention in vitamin D 
supplementation groups (figure 1). 
 
Figure 1: Pre and post 25(OH)D concentrations 
(*significantly different from pre intervention (p < 
0.05) 
 
Glycaemic control and Body mass 
A series of 2 x 2 ANOVAs failed to find an 
effect of vitamin D or exercise alone, or in 
combination on either measures of 
glycaemia (HbA1c and insulin) (p > 0.05). 
Neither was there a main effect of, or 
interaction between, vitamin D 
supplementation and exercise on body mass 
(p > 0.05). Pre and post values are reported 
in Tables 2, 3, 4 and 5. 
 
Heart Rate 
There was a significant group x time 
interaction (F(3,31) = 4.855, p = 0.01, partial 
n2 = 0.320) for exercising HR at 60 W (figure 
2). A significant reduction in exercising HR 
post- compared to pre-intervention was 
identified in the Ex+VitD group (F(1,9) = 
6.533, p = 0.03, partial n2 = 0.421), but not 
between pre and post HR at 60 W in 
NoEx+VitD group (F(1,6) = 4.531, p = 0.07, 
partial n2 = 0.430), Ex+Pla group (F(1,7) = 
0.307, p = 0.59, partial n2 = 0.042) or 
NoEx+Pla group (F(1,9) = 1.420, p = 0.22, 
partial n2 = 0.127) (figure 2).  
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Figure 2: Pre and post HR at 60 watts (*significantly 
different from pre intervention (p < 0.05) 
 
There was no main effect of time or group 
and no statistical interaction between 
groups and time on exercising HR at 90 W (p 
>0.05) (Tables 2, 3, 4 and 5). Tests were not 
conducted for other intensities as too few 
participants were able to complete the 
higher intensity stages.  
 
Table 2. Non-significant pre and post measures for 
Ex+VitD group (mean ± SD). 
 pre post 
HbA1c 
(mmol/mol) 
36.0±4.8 37.5±3.3.7 
Insulin 43.9±34.0 41.6±31.4 
Body mass (kg) 71.7±16.5 70.3±15.7 
HR (bpm) 90 W 133±22 126±20 
 
 
 
Table 3. Non-significant pre and post measures for 
NoEx+Vit D group (mean ± SD). 
 pre post 
HbA1c 
(mmol/mol) 
30.4±12.9 35.1±3.4 
Insulin 36.4±18.8 26.8±8.1 
Body mass (kg) 69.1±15.5 69.2±15.2 
HR (bpm) 90 W 149±23 144±19 
   
 
 
 
 
Table 4. Non-significant pre and post measures for 
Ex+Pla group (mean ± SD). 
 pre post 
HbA1c 
(mmol/mol) 
33.1±10.7 34.2±11.3 
Insulin 35.1±18.7 29.7±12.5 
Body mass (kg) 71.1±9.6 71.4±9.6 
HR (bpm) 90 W 133±26 125±17 
 
 
 
Table 5. Non-significant pre and post measures for 
NoEx+Pla group (mean ± SD). 
 pre post 
HbA1c 
(mmol/mol) 
24.8±14.8 35.0±5.0 
Insulin 43.4±27.6 56.0±49.0 
Body mass (kg) 78.9±25.9 78.6±25.4 
HR (bpm) 90 W 142±15 146±18 
 
 
DISCUSSION 
 
There were no significant effects of 15 weeks 
of vitamin D supplementation (2000 
IU/day) or a 15-week exercise training 
(cycling) intervention on measures of 
glycaemic control or body mass in healthy 
participants. There was a significant 
reduction in exercising HR (60 watts) in the 
exercise and vitamin D supplementation 
group only. Vitamin D concentrations in the 
supplementation group were raised to what 
many experts in the field would consider to 
be necessary (98.1±19.0 nmol/l) for benefits 
to human health (18) at a time of year (mid-
August to mid-November) when a seasonal 
decline would be expected. The placebo 
groups demonstrated a significant seasonal 
decrease of 33%, whilst a significant increase 
in 25(OH)D of 28% was observed in the 
vitamin D supplementation groups. The 
vitamin D dose in the current study was 
2000 IU/day, supplementing with a lower 
dose in line with current recommendations 
(600 IU/day: 14) may not have achieved this. 
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The absence of any independent effects of 
the exercise training program on any of the 
measures was unexpected and possibly 
attributable to the characteristics of the 
participants and/or the volume of exercise 
provided. Despite verbally self-reporting 
being “inactive” during recruitment many 
of the participants were classified 
“sufficiently active” or “active” (IPAQ) 
during the first lab visit leaving less scope 
for adaptation. The lowered HR in the 
exercise and vitamin D group suggests an 
enhancing role of vitamin D alongside the 
exercise program in reducing exercising HR. 
It is not possible to speculate whether a 
higher dose of vitamin D would have 
achieved this independently as the evidence 
in this area implies a synergistic effect of 
vitamin D in combination with exercise in 
the current study or with calcium in earlier 
work (13).  
It was suggested that the mechanism by 
which vitamin D exerted its effect on HR 
when co supplemented with calcium over 8 
weeks was mediated via a vascular smooth 
muscle mechanism as this is a target organ 
for vitamin D (13). An improvement in 
endothelial function has been observed in 
participants with type 2 diabetes following 
vitamin D supplementation (Sugden et al., 
2008), which may subsequently reduce 
peripheral resistance (19) and potentially 
HR for a given work rate as observed in the 
current study. These findings not only have 
relevance to cardiovascular adaptations in 
relation to exercise performance, but may 
well be of clinical significance as micro-
vascular events are the cause of many of the 
complications of diabetes (16).  
The absence of a vitamin D supplementation 
effect on glucose control was not totally 
unexpected as many of the participants (n = 
28) in the current study had baseline 
25(OH)D concentrations greater than 50 
nmol/l. It has been suggested that for 
vitamin D supplementation to exert any 
effect on glucose metabolism, 25(OH)D 
initial concentrations would need to below 
50 nmol/l (11). Only eight of the participants 
in the current study had 25(OH)D 
concentrations below this level.  
The non-significant effects of exercise on 
measurements of glycaemia and body mass 
were unexpected as regular exercise training 
results in a decrease of adipose tissue 
storage. In participants that are already 
“sufficiently active” or “active” it is likely 
that a higher volume of exercise training 
would be required to induce any kind of 
significant training adaptations. The degree 
of insulin resistance at baseline would affect 
the responsiveness to exercise training (8) 
and the study participants showed no signs 
of insulin resistance at baseline. This would 
result in limited scope for improvement in 
glucose in response to any intervention. 
Duration of supplementation may also be a 
contributing factor as (11) reported the effect 
of time in relation to vitamin D and glucose 
control. Despite a significant increase in 
vitamin D status at three months an effect on 
glucose control was only observed at six 
months (11).  
While the dose of vitamin D in the current 
study significantly raised 25(OH)D 
concentrations, no independent or 
interactive effects were observed when 
supplementation was combined with 
exercise on any of the measures of glycaemia 
or body mass. The identification that the 
exercise program induced a significant 
reduction in exercising HR when combined 
with vitamin D is of relevance to both an 
athletic and clinical population. Further 
investigations are required to confirm these 
findings, identify optimum vitamin D 
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concentrations in relation to outcomes 
beyond that of bone health, and explore the 
mechanisms involved.  
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